The BioEscalator, the University of Oxford’s biomedical incubator, is home to a stellar collection of companies using cutting-edge science to tackle profound medical challenges.
The new Portfolio 2025 brings them together to showcase their innovative approaches and provide a valuable guide for potential investors and partners.
The Portfolio 2025 includes:
- A foreword from Tim Funnell, Partner at Monograph Capital
- One-page profiles of tenants, from founders and funding to achievements and ambitions
- A map of their partners and investors across the world
- The alumni
- BioEscalator achievement metrics
The Portfolio 2025 is a guide to the activities of BioEscalator tenants – you can make contact with them via the details given in their profiles, or via the BioEscalator team, if you would like to know more.
